FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q38816261> ?p ?o ?g. }

• Q38816261 description "2015 nî lūn-bûn" @default.
• Q38816261 description "2015年の論文" @default.
• Q38816261 description "2015年論文" @default.
• Q38816261 description "2015年論文" @default.
• Q38816261 description "2015年論文" @default.
• Q38816261 description "2015年論文" @default.
• Q38816261 description "2015年論文" @default.
• Q38816261 description "2015年论文" @default.
• Q38816261 description "2015年论文" @default.
• Q38816261 description "2015年论文" @default.
• Q38816261 description "2015年论文" @default.
• Q38816261 description "2015年论文" @default.
• Q38816261 description "2015年论文" @default.
• Q38816261 description "2015년 논문" @default.
• Q38816261 description "article científic" @default.
• Q38816261 description "article scientific" @default.
• Q38816261 description "article scientifique" @default.
• Q38816261 description "articol științific" @default.
• Q38816261 description "articolo scientifico" @default.
• Q38816261 description "artigo científico" @default.
• Q38816261 description "artigo científico" @default.
• Q38816261 description "artigo científico" @default.
• Q38816261 description "artikel ilmiah" @default.
• Q38816261 description "artikull shkencor" @default.
• Q38816261 description "artikulong pang-agham" @default.
• Q38816261 description "artykuł naukowy" @default.
• Q38816261 description "artículo científico publicado en 2015" @default.
• Q38816261 description "artículu científicu espublizáu en 2015" @default.
• Q38816261 description "bilimsel makale" @default.
• Q38816261 description "bài báo khoa học" @default.
• Q38816261 description "naučni članak" @default.
• Q38816261 description "scienca artikolo" @default.
• Q38816261 description "scientific article published on 20 November 2015" @default.
• Q38816261 description "scientific article published on 20 November 2015" @default.
• Q38816261 description "scientific article published on 20 November 2015" @default.
• Q38816261 description "teaduslik artikkel" @default.
• Q38816261 description "tieteellinen artikkeli" @default.
• Q38816261 description "tudományos cikk" @default.
• Q38816261 description "vedecký článok" @default.
• Q38816261 description "vetenskaplig artikel" @default.
• Q38816261 description "videnskabelig artikel" @default.
• Q38816261 description "vitenskapelig artikkel" @default.
• Q38816261 description "vitskapeleg artikkel" @default.
• Q38816261 description "vědecký článek" @default.
• Q38816261 description "wetenschappelijk artikel" @default.
• Q38816261 description "wissenschaftlicher Artikel" @default.
• Q38816261 description "επιστημονικό άρθρο" @default.
• Q38816261 description "мақолаи илмӣ" @default.
• Q38816261 description "наукова стаття, опублікована в листопаді 2015" @default.
• Q38816261 description "научна статия" @default.
• Q38816261 description "научная статья" @default.
• Q38816261 description "научни чланак" @default.
• Q38816261 description "научни чланак" @default.
• Q38816261 description "מאמר מדעי" @default.
• Q38816261 description "مقالة علمية نشرت في 20 نوفمبر 2015" @default.
• Q38816261 description "২০ নভেম্বর ২০১৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q38816261 description "บทความทางวิทยาศาสตร์" @default.
• Q38816261 description "სამეცნიერო სტატია" @default.
• Q38816261 name "Co-delivery of Se nanoparticles and pooled SiRNAs for overcoming drug resistance mediated by P-glycoprotein and class III β-tubulin in drug-resistant breast cancers" @default.
• Q38816261 name "Co-delivery of Se nanoparticles and pooled SiRNAs for overcoming drug resistance mediated by P-glycoprotein and class III β-tubulin in drug-resistant breast cancers" @default.
• Q38816261 name "Co-delivery of Se nanoparticles and pooled SiRNAs for overcoming drug resistance mediated by P-glycoprotein and class III β-tubulin in drug-resistant breast cancers" @default.
• Q38816261 type Item @default.
• Q38816261 label "Co-delivery of Se nanoparticles and pooled SiRNAs for overcoming drug resistance mediated by P-glycoprotein and class III β-tubulin in drug-resistant breast cancers" @default.
• Q38816261 label "Co-delivery of Se nanoparticles and pooled SiRNAs for overcoming drug resistance mediated by P-glycoprotein and class III β-tubulin in drug-resistant breast cancers" @default.
• Q38816261 label "Co-delivery of Se nanoparticles and pooled SiRNAs for overcoming drug resistance mediated by P-glycoprotein and class III β-tubulin in drug-resistant breast cancers" @default.
• Q38816261 prefLabel "Co-delivery of Se nanoparticles and pooled SiRNAs for overcoming drug resistance mediated by P-glycoprotein and class III β-tubulin in drug-resistant breast cancers" @default.
• Q38816261 prefLabel "Co-delivery of Se nanoparticles and pooled SiRNAs for overcoming drug resistance mediated by P-glycoprotein and class III β-tubulin in drug-resistant breast cancers" @default.
• Q38816261 prefLabel "Co-delivery of Se nanoparticles and pooled SiRNAs for overcoming drug resistance mediated by P-glycoprotein and class III β-tubulin in drug-resistant breast cancers" @default.
• Q38816261 P1433 Q38816261-8EF0008B-92C1-4A2B-BDBE-DC1FCDBB2935 @default.
• Q38816261 P1476 Q38816261-4A53B4E6-C861-4426-9777-CA4CBC3744D8 @default.
• Q38816261 P2093 Q38816261-40E592DA-5D53-4A8D-AB66-454D41C20F2D @default.
• Q38816261 P2093 Q38816261-5AEC2B44-CF52-4180-9966-4C0869C71B93 @default.
• Q38816261 P2093 Q38816261-5D62F04A-C65E-41AA-A1F7-95E565F53A1A @default.
• Q38816261 P2093 Q38816261-86EB7CC6-A054-4BD1-BC90-980C5EA23EF1 @default.
• Q38816261 P2093 Q38816261-9DADA734-80C8-4629-8EC7-FB30B5A6BF21 @default.
• Q38816261 P2093 Q38816261-B1CBF81F-5CDD-4E72-AA18-797F34093706 @default.
• Q38816261 P2093 Q38816261-B5317910-605C-4C54-9CBC-65FE1C478676 @default.
• Q38816261 P2093 Q38816261-C3EBA196-921B-42DF-910B-D5ADE1F4955D @default.
• Q38816261 P2093 Q38816261-EEBE3E77-FDD6-41E9-A7D3-16141CF150AE @default.
• Q38816261 P2860 Q38816261-161B3041-FB3C-4026-8C61-F2F5232D8CFD @default.
• Q38816261 P2860 Q38816261-3E0EC58C-2E27-4F7C-9C85-708F90F60480 @default.
• Q38816261 P304 Q38816261-3BB9720F-58F8-4C47-916C-CF8832EBF7F1 @default.
• Q38816261 P31 Q38816261-E846D21F-0767-438B-83C9-5CEC99B308DC @default.
• Q38816261 P356 Q38816261-9BE57A15-CF1B-41E4-83EC-E6322846BCDC @default.
• Q38816261 P478 Q38816261-6264A0D6-FB04-40C3-8C98-00885C6FEE43 @default.
• Q38816261 P577 Q38816261-F44BE71A-95EA-48E7-B3B1-9C51F7E1AF4D @default.
• Q38816261 P698 Q38816261-54BE14B9-6BC9-499F-B9DA-1D2F6EFE3E9F @default.
• Q38816261 P921 Q38816261-CC265C8E-C7B4-4015-BF4E-E78DBA581FA3 @default.
• Q38816261 P356 J.ACTBIO.2015.11.041 @default.
• Q38816261 P698 26612416 @default.
• Q38816261 P1433 Q4676719 @default.
• Q38816261 P1476 "Co-delivery of Se nanoparticles and pooled SiRNAs for overcoming drug resistance mediated by P-glycoprotein and class III β-tubulin in drug-resistant breast cancers" @default.
• Q38816261 P2093 "Jie Liu" @default.
• Q38816261 P2093 "Lanmei Chen" @default.
• Q38816261 P2093 "Qingchang Chen" @default.
• Q38816261 P2093 "Shuang Zhao" @default.
• Q38816261 P2093 "Taoyuan Xu" @default.
• Q38816261 P2093 "Tiantian Yin" @default.
• Q38816261 P2093 "Wenjing Zheng" @default.
• Q38816261 P2093 "Xiaoquan Huang" @default.

• next